Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient

Dermatol Ther. 2020 Jul;33(4):e13668. doi: 10.1111/dth.13668. Epub 2020 Jun 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Psoriatic*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Critical Care
  • Humans
  • Infections*
  • Oligodendroglioma*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Thalidomide / analogs & derivatives

Substances

  • Thalidomide
  • apremilast